SA
Sign upLog In

Ligand Pharmaceuticals Inc (LGND)

R&D Expenses

$14.67M

Quarterly · Period ending: · USD

LGND logo

LGND R&D Expenses

Latest reported$14.67M
LGND Quarterly R&D Expenses ($0.00 → $14.67M)
High-resolution chart · PNG

LGND r&d expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Ligand Pharmaceuticals Inc R&D Expenses — Quarterly (USD)
Period endingR&D Expenses (USD)
14,668,000
2,148,000
3,511,000
21,019,000
6,567,000
50,085,000
4,425,000
5,675,000
5,354,000
5,971,000
5,488,000
5,532,000
6,854,000
6,663,000
-25,379,000
9,239,000
8,467,000
9,179,000
18,243,000
16,938,000
15,953,000
17,879,000
21,916,000
12,853,000
12,732,000
11,891,000
18,664,000
13,742,000
12,213,000
11,289,000
8,840,000
5,483,000
6,135,000
7,407,000
8,633,000
4,759,000
4,822,000
8,673,000
6,408,000
6,305,000
4,507,000
4,004,000
2,870,000
2,538,000
4,010,000
3,962,000
3,199,000
3,021,000
2,689,000
3,131,000
2,374,000
2,414,000
2,022,000
2,465,000
2,476,000
2,647,000
2,850,000
2,817,000
2,598,000
2,471,000
3,237,000
1,986,000
3,155,000
4,935,000
6,602,000
7,362,000
10,126,000
9,921,000
9,470,000
10,462,000
11,063,000
6,165,000
6,377,000
7,165,000
10,432,000
9,838,000
8,751,000
15,602,000
12,913,000
10,468,000
13,895,000
12,218,000
13,905,000
12,911,000
14,524,000
14,735,000
12,198,000
17,980,000
18,174,000
16,852,000
16,483,000
17,696,000
16,859,000
16,640,000
16,370,000
15,641,000
13,681,000
13,115,000
12,626,000
12,882,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.